Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 11/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27540613 | 0.84 | SIGMAR1 (0.49) | SIGMAR1SLC6A3 | |
| SCHEMBL27780996 | 0.82 | SIGMAR1 (0.59) | SIGMAR1MEN1CYP3A4CYP2D6TSHR | |
| SCHEMBL7495663 | 0.81 | SIGMAR1 (0.49) | SIGMAR1MEN1CYP3A4CYP2D6TSHR | |
| SCHEMBL230653 | 0.81 | SIGMAR1 (0.61) | SIGMAR1MEN1CYP3A4CYP2D6TSHR | |
| SCHEMBL23878715 | 0.76 | SIGMAR1 (0.60) | SIGMAR1MEN1CYP3A4CYP2D6TSHR | |
| SCHEMBL27717160 | 0.71 | SIGMAR1 (0.66) | SIGMAR1MEN1CYP3A4CYP2D6TSHR | |
| SCHEMBL7366815 | 0.70 | HDAC1 (0.50) | SLC6A3 | |
| SCHEMBL7253808 | 0.70 | SIGMAR1 (0.43) | SIGMAR1MEN1CYP3A4CYP2D6TSHR | |
| SCHEMBL7382599 | 0.69 | SIGMAR1 (0.55) | SIGMAR1MEN1CYP3A4CYP2D6TSHR | |
| SCHEMBL25168753 | 0.69 | HRH4 (0.48) | SIGMAR1MEN1CYP3A4CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970090-B1 | SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE | KNOLL GMBH (DE) | 2002-06-05 | — | — | EP | disclosed |
| US-6187802-B1 | 3-(1-(3,4-DICHLOROPHENYL)CYCLOBUTYL)-5,6-DIHYDROIMIDAZO(2,1-B) THIAZOLE, FOR EXAMPLE; ADMINISTERING TO TREAT DEPRESSION, ANXIETY, PARKINSON'S DISEASE, OBESITY, COGNITIVE DISORDERS, SEIZURES, AND FOR NEUROPROTECTION AGAINST STROKE | KNOLL AKTIENGESELLSCHAFT (DE) | 2001-02-13 | — | — | US | disclosed |
| EP-0970090-A1 | SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE | Knoll AG (DE) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998041528-A1 | SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE | KNOLL AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |